Exhibit 32.1
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Relay Therapeutics, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of their knowledge:
Date: February 23, 2023 |
| By: | /s/ Sanjiv K. Patel |
|
|
| Sanjiv K. Patel |
|
|
| President and Chief Executive Officer (Principal Executive Officer) |
Date: February 23, 2023 |
| By: | /s/ Thomas Catinazzo |
|
|
| Thomas Catinazzo |
|
|
| Chief Financial Officer (Principal Accounting Officer and Principal Financial Officer) |